Format

Send to

Choose Destination
Anaesth Crit Care Pain Med. 2019 Oct;38(5):451-453. doi: 10.1016/j.accpm.2019.07.005. Epub 2019 Jul 16.

Antimicrobial therapy during ECMO - customised dosing with therapeutic drug monitoring: The way to go?

Author information

1
University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, QLD, Australia.
2
Adult Intensive Care Services, The Prince Charles Hospital, Chermside, Australia; Critical Care Research Group, Centre of Research Excellence for Advanced Cardiorespiratory Therapies Improving Organ Support (ACTIONS), The University of Queensland, Brisbane, QLD, Australia.
3
University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, QLD, Australia; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia; Faculty of Medicine, The University of Queensland, Brisbane, University of Queensland Centre for Clinical Research (UQCCR), QLD, Australia. Electronic address: j.roberts2@uq.edu.au.

KEYWORDS:

Antibiotics; Extracorporeal membrane oxygenation; Pharmacokinetics; Therapeutic drug monitoring

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center